|
|
Blood, Vol. 114, Issue 9, 1729-1735, August 27, 2009

Mobilization in myeloma revisited: IMWG consensus perspectives on stem cell collection following initial therapy with thalidomide-, lenalidomide-, or bortezomib-containing regimens
Blood Kumar et al.
114: 1729
Supplemental materials for: Kumar et al
International Myeloma Working Group members: Rafat Abonour, Indiana University School of Medicine, Indianapolis, Indiana, USA Ray Alexanian, MD Anderson, Houston, Texas, USA Kenneth Anderson, DFCI, Boston, Massachusetts, USA Michael Attal, Purpan Hospital, Toulouse, France Herve Avet-Loiseau, Institute de Biologie, Nantes, France Ashraf Badros, University of Maryland, Baltimore, Maryland, USA Leif Bergsagel, Mayo Clinic Scottsdale, Scottsdale, Arizona, USA Joan Bladé, Hospital Clinica, Barcelona, Spain Bart Barlogie, M.I.R.T. UAMS Little Rock, Arkanas, USA Regis Batille, Institute de Biologie, Nantes, France Meral Beksac, Ankara University, Ankara, Turkey Andrew Belch, Cross Cancer Institute, Alberta,Canada Bill Bensinger, Fred Hutchinson Cancer Center, Seattle, Washington, USA Mario Boccadoro, University of Torino, Torino, Italy Michele Cavo, Universita di Bologna, Bologna, Italy Wen Ming Chen, MM Research Center of Beijing, Beijing, China Tony Child, Leeds General Hospital, Leeds, United Kingdom James Chim, Department of Medicine, Queen Mary Hospital, Hong Kong Ray Comenzo, Memorial Sloane-Kettering, New York City, New York, USA John Crowley, Cancer Research and Biostatistics, Seattle, Washington, USA William Dalton, H. Lee Moffitt, Tampa, Florida, USA Faith Davies, Royal Marsden Hospital, London, England Cármino de Souza, Univeridade de Campinas, Caminas, Brazil Michel Delforge, University Hospital Gasthuisberg, Leuven, Belgium Meletios Dimopoulos, Alexandra Hospital, Athens, Greece Angela Dispenzieri, Mayo Clinic, Rochester, Minnesota, USA Brian G.M. Durie, Cedars-Sinai Outpatient Cancer Center, Los Angeles, California, USA Hermann Einsele, Universitätsklinik Würzburg, Würzburg, Germany Theirry Facon, Centre Hospitalier Regional Universitaire de Lille, Lille, France Dorotea Fantl, Socieded Argentinade Hematolgia, Buenos Aires, Argentina Jean-Paul Fermand, Hopitaux de Paris, Paris, France Rafael Fonseca, Mayo Clinic Arizona, Scottsdale, Arizona, USA Gosta Gahrton, Karolinska Institute for Medicine, Huddinge, Sweden Morie Gertz, Mayo Clinic, Rochester, Minnesota, USA John Gibson, Royal Prince Alfred Hospital, Sydney, Australia Sergio Giralt, MD Anderson Cancer Center, Houston, Texas, USA Hartmut Goldschmidt, University Hospital Heidelberg, Heidelberg, Germany Philip Greipp, Mayo Clinic, Rochester, Minnesota, USA Roman Hajek, Brno University, Brno, Czech Republic Izhar Hardan, Tel Aviv University, Tel Aviv, Israel Jean-Luc Harousseau, Institute de Biologie, Nantes, France Hiroyuki Hata, Kumamoto University Hospital, Kumamoto, Japan Yutaka Hattori, Keio University School of Medicine, Tokyo, Japan Joy Ho, Royal Prince Alfred Hospital, Sydney, Australia Vania Hungria, Clinica San Germano, Sao Paolo, Brazil Shinsuke Ida, Nagoya City University Medical School, Nagoya, Japan Peter Jacobs, Constantiaberg Medi-Clinic, Plumstead, South Africa Sundar Jagannath, St. Vincent’s Comprehensive Cancer Center, New York, New York, USA Hou Jian, Shanghai Chang Zheng Hospital, Shanghai, China Douglas Joshua, Royal Prince Alfred Hospital, Sydney, Australia Michio Kawano, Yamaguchi University, Ube, Japan Nicolaus Kröger, University Hospital Hamburg, Hamburg, Germany Shaji Kumar, Department of Hematology, Mayo Clinic, Minnesota, USA Robert Kyle, Department of Laboratory Med. and Pathology, Mayo Clinic, Minnesota, USA Juan Lahuerta, Grupo Espanol di Mieloma, Hospital Universitario, Madrid, Spain Jae Hoon Lee, Gachon University Gil Hospital, Incheon, Korea Xavier LeLeu, Hospital Huriez, CHRU Lille, France Suzanne Lentzsch, University of Pittsburgh, Pittsburgh, Pennsylvania, USA Henk Lokhorst, University Medical CenterUtrecht, Utrecht, The Netherlands Sagar Lonial, Emory University Medical School, Atlanta, Georgia, USA Heinz Ludwig, Wilhelminenspital Der Stat Wien, Vienna, Austria Angelo Maiolino, Rua fonte da Saudade, Rio de Janeiro, Brazil Maria Mateos, University of Salamanca, Salamanca, Spain Jayesh Mehta, Northwestern University, Chicago, Illinois, USA GianPaolo Merlini, University of Pavia, Pavia, Italy Joseph Mikhael, Mayo Clinic Arizona, Scottsdale, Arizona, USA Philippe Moreau, University Hospital, Nantes, France Gareth Morgan, Royal Marsden Hospital, London, England Nikhil Munshi, Diane Farber Cancer Institute, Boston, Massachusetts, USA Ruben Niesvizky, Weill Medical College of Cornell University, New York, New York, USA Yana Novis, Hospital SírioLibanês, Bela Vista, Brazil Amara Nouel, Hospital Rutz y Paez, Bolivar, Venezuela Robert Orlowski, MD Anderson Cancer Center, Houston, Texas, USA Antonio Palumbo, Cathedra Ematologia, Torino, Italy Santiago Pavlovsky, Fundaleu, Buenos Aires, Argentina Linda Pilarski, University of Alberta, Alberta, Canada Raymond Powles, Leukaemia & Myeloma, Wimbledon, England S. Vincent Rajkumar, Mayo Clinic, Rochester, Minnesota, USA Donna Reece, Princess Margaret Hospital, Toronto, Canada Tony Reiman, Cross Cancer Institute, Alberta, Canada Paul Richardson, Dana Farber Cancer Institute, Boston, Massachusetts, USA Angelina Rodriquez Morales, Bonco Metro Politano de Sangre, Caracas, Venezuela Orhan Sezer, Department of Hem/Onc, Universitatsklinikum Charite, Berlin, Germany John Shaughnessy, M.I.R.T. UAMS, Little Rock, Arkansas, USA Kazuyuki Shimizu, Nagoya City Midori General Hospital, Nagoya, Japan David Siegel, Hackensack, Cancer Center, Hackensack, New Jersey, USA Jesus San Miguel, University of Salamanca, Salamanca, Spain Chaim Shustik, McGill University, Montreal, Canada Seema Singhal, Northwestern University, Chicago, Illinois, USA Pieter Sonneveld, Erasmus MC, Rotterdam, The Netherlands Andrew Spencer, The Alfred Hospital, Melbourne, Australia Edward Stadtmauer, University of Pennsylvania, Philadelphia, Pennsylvania, USA Keith Stewart, Mayo Clinic Arizona, Scottsdale, Arizona, USA Patrizia Tosi, Italian Cooperative Group, Istituto di Ematologia Seragnoli, Bologna, Italy Guido Tricot, Huntsman Cancer Institute, Salt Lake City, Utah, USA Ingemar Turesson, Department of Hematology, Malmo University, Malmo, Sweden Brian Van Ness, University of Minnesota, Minneapolis, Minnesota, USA Ivan Van Riet, Brussels Vrija University, Brussels, Belgium Robert Vescio, Cedars-Sinai Cancer Center, Los Angeles, California, USA David Vesole, Loyola University Chicago, Illinois, USA Anders Waage, University Hospital, Trondheim, Norway NSMG Michael Wang, M.D. Anderson, Houston, Texas, USA Donna Weber, MD Anderson, Houston, Texas, USA Jan Westin, Sahlgrenska University Hospital, Gothenburg, Sweden Keith Wheatley, University of Birmingham, Birmingham, United Kingdom Dina B. Yehuda, Department of Hematology, Hadassah University Hospital, Hadassah, Israel Jeffrey Zonder, SWOG, Department of Hem/Onc., Karmanos Cancer Institute, Michigan, USA
|
|